SEC Tracker
Get the app
GKOS · XBRL financial data

GLAUKOS financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (GKOS's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers82,365*85,62295,69096,670105,499*106,664124,120133,537143,121*150,571185,610211,030
Cost of goods and services sold18,891*20,25822,55022,58428,635*24,31626,89628,83131,771*33,33934,01631,164
Gross profit63,474*65,36473,14074,08676,864*82,34897,224104,706—117,232151,594179,866
Research and development———————26,859———30,953
Selling, general and administrative63,034*61,97566,18864,00069,003*70,67383,37582,99994,700*92,943116,060130,943
General and administrative———————42,792———75,705
Total operating expenses102,096*104,430103,11498,746105,530*103,026119,913121,071138,351*137,088168,861179,038
Operating income (loss)(38,622)*(39,066)(29,974)(24,660)(28,666)*(20,678)(22,689)(16,365)(139,868)*(19,856)(17,267)828
Interest expense3,428*3,4503,3551,6631,572*1,1631,1511,1751,146*1,1251,4591,087
Other income (expense)2,420*(1,028)(1,701)2,391(5,950)*9451,857(1,009)(1,314)*(749)(1,274)87
Income tax expense (benefit)61*377331177(114)*326248234(6,159)*484656303
Net income (loss)(36,779)*(40,838)(50,545)(21,409)(33,580)*(18,146)(19,657)(16,231)(133,657)*(19,783)(18,377)2,018
Earnings per share, basic USD per share(0.75)*(0.82)(1.00)(0.39)(0.60)*(0.32)(0.34)(0.28)(2.32)*(0.34)(0.31)0.03
Earnings per share, diluted USD per share(0.75)*(0.82)(1.00)(0.39)(0.60)*(0.32)(0.34)(0.28)(2.32)*(0.34)(0.31)0.03
Weighted average shares, basic thousands of shares48,881*49,58050,71555,03755,631*56,63757,20557,39857,508*58,02258,81859,105
Weighted average shares, diluted thousands of shares48,881*49,58050,71555,03755,631*56,63757,20557,39857,508*58,02258,81861,196

Balance sheet

CSV

Fiscal quarters (GKOS's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents93,46742,49568,075100,143169,626114,252100,81398,24690,813104,249114,485162,327
Accounts receivable39,85046,54551,21756,40860,74471,53182,98598,684108,608119,691138,900150,004
Inventory41,98650,18556,48059,89557,67859,46064,62163,86363,56462,38459,30661,032
Prepaid and other current assets18,19419,02014,42018,50612,45514,85713,67318,50924,05226,99331,34631,915
Total current assets395,461388,610383,781397,282449,792444,544436,065454,768474,984485,753515,778579,650
Property and equipment, net103,212101,858100,23098,58197,86796,810111,816110,944113,253112,432112,114112,068
Right-of-use asset27,14626,68326,43027,32130,25432,17631,98531,53631,52731,02531,27130,795
Goodwill66,13466,13466,13466,13466,13466,13466,71066,71066,71066,71066,71066,710
Total assets940,414933,338919,675926,543974,756966,178986,958999,378893,487893,326920,521979,529
Accounts payable13,44012,75211,56011,10313,02615,82513,68419,88324,62419,15319,13924,407
Accrued liabilities60,57459,48658,52360,58162,09952,70465,45267,63376,65170,26283,190102,319
Total current liabilities74,01472,23870,08371,68475,12568,52979,13687,516101,27589,415102,329126,726
Lease liability, non-current30,42730,11029,91230,65633,93636,32136,20035,84735,76735,31335,49135,057
Total liabilities478,648482,608254,516258,034207,825202,219221,846229,835237,332222,398238,035262,255
Accumulated deficit(599,067)(639,905)(690,450)(711,859)(745,439)(763,585)(783,242)(799,473)(933,130)(952,913)(971,290)(969,272)
Total stockholders' equity461,766450,730665,159668,509766,931763,959765,112769,543656,155670,928682,486717,274
Total liabilities and equity940,414933,338919,675926,543974,756966,178986,958999,378893,487893,326920,521979,529
Common shares outstanding (cover page) thousands of shares49,47050,36854,95055,13756,56757,14157,35057,43558,07958,73458,98459,197

Cash flows

CSV

Fiscal quarters (GKOS's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(36,779)*(40,838)(50,545)(21,409)(33,580)*(18,146)(19,657)(16,231)(133,657)*(19,783)(18,377)2,018
Stock-based compensation12,987*11,16511,313*14,420*13,309*12,98618,019*14,913*17,300*19,14428,865*17,773*
Depreciation and amortizationyear only8,9138,998*8,999*8,740*8,2278,569*9,133*12,164*11,7978,870*8,953*
Net cash from operating activities(10,665)*(33,870)(18,369)*(9,586)*507*(18,521)6,979*(10,090)*6,843*(12,526)14,823*38,570*
Purchases of property and equipment4,214*9682,149*1,450*1,733*1,9381,179*1,635*2,914*3,9592,738*2,079*
Net cash from investing activities(12,921)*(29,383)34,864*30,563*11,787*(36,948)(20,782)*(3,993)*(15,890)*10,504(5,306)*(5,541)*
Net cash from financing activities7,303*13,1678,592*9,668*60,113*1,9502,245*5,264*2,427*15,769991*14,685*
Net change in cash(15,462)*(50,972)24,457*32,068*69,483*(55,374)(14,338)*(2,567)*(7,433)*13,4369,517*47,842*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingQuarter
GLAUKOS162,327211,03038,570*59.2M 10-QSep 30, 2026
Merit Medical Systems503,551416,24465,273*59.9M 10-QSep 30, 2026
MSA Safety187,248536,43082,312*38.5M 10-QSep 30, 2026
Globus Medical507,745789,612209,741*134.3M 10-QJun 30, 2026
iRhythm Holdings246,679224,17251,080*33.0M 10-QJun 30, 2026
TransMedics Group491,113189,94817,309*34.7M 10-QJun 30, 2026
Integer Holdings14,135449,66136,631*34.0M 10-QOct 2, 2026
Masimo124,600403,60045,30052.4M 10-QApr 4, 2026
Inspire Medical Systems190,803206,69546,426*29.0M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.